| Life Care Center Of The Willows | |
| 1000 Elizabeth Dr, Valparaiso, Indiana 46383 | |
| (219) 464-4858 | |
| Name | Life Care Center Of The Willows |
|---|---|
| Location | 1000 Elizabeth Dr, Valparaiso, Indiana |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 100 |
| Occupancy Rate | 57.4% |
| Medicare ID (CCN) | 155158 |
| Legal Business Name | Hendricks County Hospital |
| Ownership Type | Government - County |
| NPI Number | 1194772087 |
| Organization Name | HENDRICKS COUNTY HOSPITAL |
| Doing Business As | LIFE CARE CENTER OF WILLOWS |
| Address | 1000 Elizabeth St, Valparaiso, IN 46383 |
| Phone Number | 219-464-4858 |
News Archive
It is well known that aspirin, a non-selective, non-steroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX), reduces the risk of heart attack and stroke.
Pfizer Inc. and Auxilium Pharmaceuticals, Inc. today announced that Pfizer received notification from the European Medicines Agency that the Marketing Authorization Application (MAA) for XIAFLEX™ (collagenase clostridium histolyticum), a novel, first-in-class, biologic for the treatment of Dupuytren's contracture (a condition resulting in the contracture of the fingers into the palm), has completed the validation phase successfully. As a result, the scientific/technical review procedure commenced on 21 January 2010.
The National Institutes of Health (NIH) has awarded Albert Einstein College of Medicine of Yeshiva University a five-year, $11.2 million grant to study the impact of damage to DNA on aging and disease. Research funded by this grant, and conducted by a consortium of scientists, could reveal the role of genome maintenance systems in delaying aging and will begin to explore novel interventions to maintain health in old age.
A new study conservatively estimates that one in five women with ovarian cancer has inherited genetic mutations that increase the risk of the disease, according to research at Washington University School of Medicine in St. Louis.
Researchers from Biotech Research & Innovation Centre (BRIC) at University of Copenhagen have identified a new group of proteins that regulate the function of stem cells. The results are published in the new issue of Cell.
› Verified 3 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
It is well known that aspirin, a non-selective, non-steroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX), reduces the risk of heart attack and stroke.
Pfizer Inc. and Auxilium Pharmaceuticals, Inc. today announced that Pfizer received notification from the European Medicines Agency that the Marketing Authorization Application (MAA) for XIAFLEX™ (collagenase clostridium histolyticum), a novel, first-in-class, biologic for the treatment of Dupuytren's contracture (a condition resulting in the contracture of the fingers into the palm), has completed the validation phase successfully. As a result, the scientific/technical review procedure commenced on 21 January 2010.
The National Institutes of Health (NIH) has awarded Albert Einstein College of Medicine of Yeshiva University a five-year, $11.2 million grant to study the impact of damage to DNA on aging and disease. Research funded by this grant, and conducted by a consortium of scientists, could reveal the role of genome maintenance systems in delaying aging and will begin to explore novel interventions to maintain health in old age.
A new study conservatively estimates that one in five women with ovarian cancer has inherited genetic mutations that increase the risk of the disease, according to research at Washington University School of Medicine in St. Louis.
Researchers from Biotech Research & Innovation Centre (BRIC) at University of Copenhagen have identified a new group of proteins that regulate the function of stem cells. The results are published in the new issue of Cell.
› Verified 3 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 17.2 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 18.39 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 52.87 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 2.54 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0.53 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 3.11 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 4.27 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.53 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 9.95 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 89.29 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 11.54 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 36.78 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 21.54 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 11.68 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 72.96 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 82.28 | 82.93 |
News Archive
It is well known that aspirin, a non-selective, non-steroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX), reduces the risk of heart attack and stroke.
Pfizer Inc. and Auxilium Pharmaceuticals, Inc. today announced that Pfizer received notification from the European Medicines Agency that the Marketing Authorization Application (MAA) for XIAFLEX™ (collagenase clostridium histolyticum), a novel, first-in-class, biologic for the treatment of Dupuytren's contracture (a condition resulting in the contracture of the fingers into the palm), has completed the validation phase successfully. As a result, the scientific/technical review procedure commenced on 21 January 2010.
The National Institutes of Health (NIH) has awarded Albert Einstein College of Medicine of Yeshiva University a five-year, $11.2 million grant to study the impact of damage to DNA on aging and disease. Research funded by this grant, and conducted by a consortium of scientists, could reveal the role of genome maintenance systems in delaying aging and will begin to explore novel interventions to maintain health in old age.
A new study conservatively estimates that one in five women with ovarian cancer has inherited genetic mutations that increase the risk of the disease, according to research at Washington University School of Medicine in St. Louis.
Researchers from Biotech Research & Innovation Centre (BRIC) at University of Copenhagen have identified a new group of proteins that regulate the function of stem cells. The results are published in the new issue of Cell.
› Verified 3 days ago
Golden Living Center-valparaiso Location: 251 Sturdy Rd, Valparaiso, Indiana 46383 Phone: (219) 462-6158 | |
Life Care Center Of The Willows Location: 1000 Elizabeth Dr, Valparaiso, Indiana 46383 Phone: (219) 464-4858 | |
Valparaiso Care & Rehabilitation Location: 606 Wall Street, Valparaiso, Indiana 46383 Phone: (219) 464-4976 | |
Life Care Center Of Valparaiso Location: 3405 N Campbell Rd, Valparaiso, Indiana 46385 Phone: (219) 462-1023 | |
Avalon Springs Health Campus Location: 2400 Silhavy Road, Valparaiso, Indiana 46383 Phone: (219) 462-1778 |